Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Characterization of therapeutic antibody fragmentation using automated capillary western blotting as an orthogonal analytical technique.

Zhu Y, Ahluwalia D, Chen Y, Belakavadi M, Katiyar A, Das TK.

Electrophoresis. 2019 Jul 4. doi: 10.1002/elps.201900119. [Epub ahead of print]

PMID:
31271455
2.

A three-point identity criteria tool for establishing product identity using icIEF method.

Ahluwalia D, Belakavadi M, Das TK, Katiyar A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:271-277. doi: 10.1016/j.jchromb.2018.02.042. Epub 2018 Mar 1.

PMID:
29554523
3.

ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.

Jin F, Irshad S, Yu W, Belakavadi M, Chekmareva M, Ittmann MM, Abate-Shen C, Fondell JD.

Mol Cancer Res. 2013 Jul;11(7):736-47. doi: 10.1158/1541-7786.MCR-12-0618. Epub 2013 Mar 28.

4.

Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events.

Belakavadi M, Dell J, Grover GJ, Fondell JD.

Mol Cell Endocrinol. 2011 Jun 6;339(1-2):72-80. doi: 10.1016/j.mce.2011.03.016. Epub 2011 Mar 31.

PMID:
21458529
5.

Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Belakavadi M, Saunders J, Weisleder N, Raghava PS, Fondell JD.

Endocrinology. 2010 Jun;151(6):2946-56. doi: 10.1210/en.2009-1241. Epub 2010 Apr 14.

6.

Cyclin-dependent kinase 8 positively cooperates with Mediator to promote thyroid hormone receptor-dependent transcriptional activation.

Belakavadi M, Fondell JD.

Mol Cell Biol. 2010 May;30(10):2437-48. doi: 10.1128/MCB.01541-09. Epub 2010 Mar 15.

7.

MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling.

Belakavadi M, Pandey PK, Vijayvargia R, Fondell JD.

Mol Cell Biol. 2008 Jun;28(12):3932-42. doi: 10.1128/MCB.02191-07. Epub 2008 Apr 7.

8.

Purification and characterization of butyrate-induced protein phosphatase involved in apoptosis of Ehrlich ascites tumor cells.

Belakavadi M, Prabhakar BT, Salimath BP.

Biochim Biophys Acta. 2007 Jan;1770(1):39-47. Epub 2006 Jul 21.

PMID:
17029793
9.

Role of the mediator complex in nuclear hormone receptor signaling.

Belakavadi M, Fondell JD.

Rev Physiol Biochem Pharmacol. 2006;156:23-43. Review.

PMID:
16634145
10.

Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1.

Udayakumar TS, Belakavadi M, Choi KH, Pandey PK, Fondell JD.

J Biol Chem. 2006 May 26;281(21):14691-9. Epub 2006 Mar 30.

11.

Butyrate-induced proapoptotic and antiangiogenic pathways in EAT cells require activation of CAD and downregulation of VEGF.

Belakavadi M, Prabhakar BT, Salimath BP.

Biochem Biophys Res Commun. 2005 Oct 7;335(4):993-1001.

PMID:
16105646
12.
13.

Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation.

Gururaj AE, Belakavadi M, Salimath BP.

Mol Cell Biochem. 2003 Jan;243(1-2):107-12.

PMID:
12619895
14.

Molecular mechanisms of anti-angiogenic effect of curcumin.

Gururaj AE, Belakavadi M, Venkatesh DA, Marmé D, Salimath BP.

Biochem Biophys Res Commun. 2002 Oct 4;297(4):934-42.

PMID:
12359244

Supplemental Content

Loading ...
Support Center